Amundi Pioneer Asset Management Inc. cut its holdings in Davita Inc (NYSE:DVA) by 2.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 117,318 shares of the company’s stock after selling 3,207 shares during the quarter. Amundi Pioneer Asset Management Inc. owned approximately 0.07% of Davita worth $6,038,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in DVA. Quantamental Technologies LLC acquired a new position in shares of Davita during the fourth quarter valued at about $34,000. Fort L.P. acquired a new position in shares of Davita during the fourth quarter valued at about $76,000. Honkamp Krueger Financial Services Inc. acquired a new position in shares of Davita during the third quarter valued at about $143,000. Dupont Capital Management Corp increased its holdings in shares of Davita by 41.0% during the fourth quarter. Dupont Capital Management Corp now owns 2,525 shares of the company’s stock valued at $130,000 after acquiring an additional 734 shares in the last quarter. Finally, Captrust Financial Advisors increased its holdings in shares of Davita by 96.8% during the third quarter. Captrust Financial Advisors now owns 3,050 shares of the company’s stock valued at $218,000 after acquiring an additional 1,500 shares in the last quarter. 88.44% of the stock is owned by institutional investors.
Several research firms have recently issued reports on DVA. Royal Bank of Canada restated a “hold” rating and set a $65.00 price objective on shares of Davita in a report on Wednesday, January 9th. SunTrust Banks restated a “hold” rating on shares of Davita in a report on Wednesday, February 20th. Zacks Investment Research upgraded shares of Davita from a “sell” rating to a “hold” rating in a report on Thursday, February 14th. ValuEngine downgraded shares of Davita from a “hold” rating to a “sell” rating in a report on Wednesday, January 2nd. Finally, UBS Group upgraded shares of Davita from a “sell” rating to a “neutral” rating and cut their price target for the stock from $64.00 to $59.00 in a report on Tuesday, January 8th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $66.92.
Davita (NYSE:DVA) last issued its quarterly earnings results on Wednesday, February 13th. The company reported $0.90 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.89 by $0.01. Davita had a net margin of 1.40% and a return on equity of 14.17%. The company had revenue of $2.82 billion for the quarter, compared to the consensus estimate of $2.97 billion. During the same quarter in the prior year, the company earned $0.92 EPS. Davita’s quarterly revenue was up 1.4% on a year-over-year basis. Equities research analysts predict that Davita Inc will post 4.43 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Amundi Pioneer Asset Management Inc. Decreases Holdings in Davita Inc (NYSE:DVA)” was originally posted by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://www.baseballdailydigest.com/news/2019/04/24/davita-inc-dva-stake-decreased-by-amundi-pioneer-asset-management-inc.html.
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Featured Article: Outstanding Shares and The Effect on Share Price
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.